Interactive Tools ¶
📚
How Cultured Chicken Is Made
Cost-focused production overview with video explainers, key papers, and interactive calculation tools.
🔬
TEA Comparison
Side-by-side comparison of what Pasitka, Humbird, CE Delft, GFI, and Goodwin actually say — and where they differ.
Technical documentation: model methodology & parameter reference →
Audio Overviews ¶
►Audio overviews · AI-generated · note
Workshop Presentations ¶
Aleksandra Fuchs (ACIB) — FEASTS: Hydrolysates as full basal medium substitution + circular cell culture Download slides (PDF, 2.7 MB) →
Presented in S1 (11:30–11:50 ET, May 8). Covers the FEASTS process for replacing purified amino acids with plant/yeast hydrolysates as a full basal medium, and implications for media cost reduction.
Suggested Reading ¶
Know a paper we should add? Annotate this page via the Hypothes.is sidebar.
No pre-reading is required for the workshop. These are for participants who want to engage with the primary evidence. Starred items are highest priority.
Core TEAs — the disagreement
⭐ Pasitka et al. (2024) — Nature Food. "Empirical economic analysis shows cost-effective continuous manufacturing of cultivated chicken using animal-free medium." The optimistic case: ~$13/kg (~$6/lb) with continuous production. (author disclosure)Authors were affiliated with Believer Meats. The paper's technical analysis stands on its own merits and should be evaluated independently of the company's subsequent history.
⭐ Humbird (2021) — Open Philanthropy. "Scale-up economics for cultured meat." The pessimistic case: $38–51/kg (~$17–23/lb), "extreme, intractable technical challenges at food scale."
⭐ Goodwin, Aimutis & Shirwaiker (2024) — Nature Food. "A scoping review of cultivated meat techno-economic analyses." Neutral review: where the TEAs agree and disagree. Concludes CM is "unlikely to be competitive under the current paradigm."
CE Delft (2021) — landing page · PDF (corrigendum). "TEA of cultivated meat: Future projections for different scenarios." Industry-standard reference, moderate projections.
Media costs & supply chain
⭐ GFI amino acid report (Dec 2025) — GFI · executive summary PDF. Based on quotes from amino acid suppliers and CM manufacturers. Reports that Humbird's amino acid prices may be overestimated by 2–10x.
More on media costs & supply chain (GFI and others)
GFI cell growth modeling (Nov 2025) — GFI. Reviews empirical and energetics-based cell growth models; identifies data gaps limiting current TEAs.
GFI growth factor costs (2023) — PDF. Anticipated growth factor and recombinant protein costs and volumes for cost-competitive CM.
GFI medium cost analysis (2020) — GFI. Foundational analysis identifying recombinant proteins and growth factors as key cost drivers.
GFI scale-up & bioprocessing trends (2024) — GFI. Industry trends in bioreactor scale, perfusion, and food-grade equipment.
Note: GFI is the most prolific publisher of CM supply chain data. We welcome suggestions for non-GFI sources on media costs — annotate this page or email contact@unjournal.org.
► Forecasting & industry outlook (2 items)
Dullaghan & Zhang (2022) — Rethink Priorities · Unjournal evaluation. "Forecasts estimate limited cultured meat production through 2050." Evaluators noted the work as valuable but somewhat dated given subsequent TEA developments.
Lever VC (Apr 2025) — Lever VC. "A Second Generation of Cultivated Meat Companies Breaks Through Projected Cost Barriers." Claims media costs 30x lower than predicted. Note: authored by CM investors.
Environmental & broader context (?)This workshop focuses on production costs rather than environmental consequences, but environmental claims affect consumer and regulatory acceptance — which in turn affect commercial viability and scale.
Risner et al. (2024) — ACS Food Sci & Tech. Life cycle assessment finding CM's global warming potential could be 4–25x greater than retail beef if pharmaceutical-grade purification is required.
Swartz, Nahmias & Tuomisto (2025) — Comment. Critique of Risner et al.'s assumptions. (key divergences)Swartz et al. argue Risner's LCA assumes pharmaceutical-grade inputs (~20x more energy than food-grade), an outdated 2010 energy grid mix, and media volumes of 291-1,148 L/kg vs recent data showing 65-120 L/kg. With food-grade inputs and updated grid projections, they find CM could produce up to 70% fewer GHG emissions than beef — the opposite conclusion.
Risner et al. (2025) — Rebuttal. Maintains that scaling uncertainties remain significant; food-grade assumptions are aspirational, not demonstrated at commercial scale.
Unjournal EA Forum post (Jul 2025) — EA Forum. "Is cultured meat commercially viable? Unjournal's first Pivotal Question." Background on the project, focal questions, and research pipeline.
► Additional reading compiled by an external evaluator (media, cell lines, approved products)
Compiled by an independent subject-matter evaluator as part of Evaluation 2 of the Dullaghan & Zhang forecast — outside the workshop, reflecting that evaluator's own selection and emphasis. A supplementary starting point, not a workshop-endorsed list. The approved-products table was assembled from the evaluator's knowledge, published sources, and AI tools (NotebookLM, Perplexity) and may contain errors — verify before citing.
Media & cell-line cost (high relevance)
Quek et al. (2024) — npj Science of Food. Cost-reduction strategies for serum-free media.
Leber et al. (2025) — SSRN preprint. Cost-effective, sustainable media formulations for cellular agriculture.
Stout et al. (2022) — Communications Biology. Serum-free medium for bovine satellite-cell expansion (Kaplan lab).
Pasitka et al. (2022) — Nature Food. Spontaneously immortalized chicken fibroblast lines for serum-free production.
FDA pre-market consultations — inventory. Company dossiers with process and media detail.
Albumin & cell-line engineering
Stout et al. (2023) — Biomaterials. "Beefy-R" — replacing albumin with rapeseed protein isolates.
Cell-line engineering review (2024) — iScience. Unlocking CM through cell-line engineering (incl. Flack, Kaplan).
New TEA & lower relevance
Aleph Farms TEA (2025) — company TEA. Claims 47% margin at price parity with beef cuts. (company-authored)
Kim et al. (2023) — Future Foods. Culture temperature for chicken satellite cells.
Air-lift bioreactor design (2020) — Chem. Eng. Science. Conceptual large-scale reactor for animal-cell cultivation.
Approved CM products (evaluator's compilation — verify before citing)
| Company / product | Region(s) | Type | Cell source | Approval (authority, year) |
|---|---|---|---|---|
| GOOD Meat (Eat Just) | Singapore, USA | Chicken | Immortalized fibroblasts (unmodified) | Singapore 2020; FDA & USDA 2023 |
| UPSIDE Foods | USA | Chicken | Myoblast/fibroblast lines (some GM) | FDA & USDA 2023 |
| Vow (Forged) | Singapore, AU, NZ | Quail | Quail embryonic fibroblasts | Singapore 2024; FSANZ 2025 |
| Aleph Farms | Israel, CH, UK | Beef | Bovine embryonic stem cells | Israel 2024; EU/UK under review |
| Believer Meats | Israel, USA | Chicken | Immortalized chicken cells | FDA "no questions" 2025 |
| Mission Barns | USA | Pork fat | Cultivated pork-fat cells | USDA 2025 |
| Wildtype | USA | Salmon | Salmon muscle cells | FDA consultation completed 2025 |
| Meatly | UK | Chicken (pet food) | Not specified | UK approved (pet food) |
Ready to state your beliefs? Go to the Pivotal Questions form →
Pivotal Questions Database ¶
The full set of operationalized questions (CM_01–CM_20), research scoping, and evaluator instructions are maintained on Coda:
CM PQ specifications → — Full question definitions and resolution criteria
Research scoping (CM) → — Papers under consideration for evaluation
Evaluator instructions → — What we ask PQ evaluators to do
CM_01 on Metaculus → — Forecast the focal cost question